Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Endocrine 1Breast 1

Conditions

Urinary Bladder Neoplasms 2Prostatic Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Adrenocortical Carcinoma 1

Interventions

Trastuzumab 2Cyclophosphamide 2tipifarnib 1relacorilant 1pembrolizumab 1fludarabine phosphate 1entinostat 1avelumab 1Suramin 1Specimen Handling 1Nivolumab 1N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride 1Magnetic Resonance Spectroscopy 1Interleukin-13 1Interleukin-12 Subunit p35 1Interleukin-12 1IPI-549 1Fluorodeoxyglucose F18 1E-7386 1Doxorubicin 1Cytoreduction Surgical Procedures 1Cisplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Adrenocortical Carcinoma × Suramin × Clear all
NCT00003038 2011-08-03

Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors

Mayo Clinic

Phase 1 Completed
BreastEndocrineGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡